753
Views
5
CrossRef citations to date
0
Altmetric
Clinical Study

Utility of cystatin C-derived equations for evaluation of residual renal function in peritoneal dialysis patients

, , &
Pages 50-56 | Received 24 May 2014, Accepted 30 Aug 2014, Published online: 30 Sep 2014

References

  • Maiorca R, Brunori G, Zubani R, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant. 1995;10(12):2295–2305
  • Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis. 1999;33(3):523–534
  • Szeto CC, Wong TY, Leung CB, et al. Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients. Kidney Int. 2000;58(1):400–407
  • Rocco M, Soucie JM, Pastan S, McClellan WM. Peritoneal dialysis adequacy and risk of death. Kidney Int. 2000;58(1):446–457
  • Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol. 1996;7(2):198–207
  • Bargman JM, Golper TA. The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant. 2005;20(4):671–673
  • Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006;69(10):1726–1732
  • Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant. 2007;22(6):1633–1638
  • Yang Q, Li R, Zhong Z, et al. Is cystatin C a better marker than creatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis? Nephrol Dial Transplant. 2011;26(10):3358–3365
  • Carter JL, Lane CE, Fan SL, Lamb EJ. Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: Comparison with 51Cr-EDTA clearance. Nephrol Dial Transplant. 2011;26(11):3729–3732
  • Ros S, Bajo A, del Peso G, et al. Cystatin C as marker of residual renal function in patients on peritoneal dialysis: relation with parameters of peritoneal function. J Nephrol. 2007;20(4):468–473
  • Delaney MP, Stevens PE, Al Hasani M, Stowe HJ, Judge C, Lamb EJ. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: A cross-sectional study. Am J Kidney Dis. 2008;51(2):278–284
  • Khorgami Z, Abdollahi A, Soleimani S, Ahamadi F, Mahdavi-Mazdeh M. Relationship between serum cystatin C and creatinine or dialysis adequacy in patients on chronic maintenance hemodialysis. Nephro-Urol Monthly. 2013;5(2):733–735
  • Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29–34
  • Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function – A review. Clin Chem Lab Med. 1999;37(4):389–395
  • Laterza OF, Price CP, Scott MG. Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem. 2002;48(5):699–707
  • Menon V, Shlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Int Med. 2007;147(1):19–27
  • Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. New Engl J Med. 2005;352(20):2049–2060
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612
  • Pannekeet MM, Imholz AL, Struijk DG, et al. The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int. 1995;48(3):866–875
  • van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1996;7(5):745–750
  • Gehan EA, George SL. Estimation of human body surface area from height and weight. Cancer Chemother Rep 1. 1970;54(4):225–235
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–310
  • Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421
  • Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652–660
  • Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyo F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron. 2002;91(1):13–20
  • Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis. 2002;40(2):221–226
  • Mulay A, Biyani M, Akbari A. Cystatin C and residual renal function in patients on peritoneal dialysis. Am J Kidney Dis. 2008;52(1):194–195; author reply 5–6
  • Al-Wakeel JS, Hammad D, Memon NA, Tarif N, Shah I, Chaudhary A. Serum cystatin C: A surrogate marker for the characteristics of peritoneal membrane in dialysis patients. Saudi J Kidney Dis Transplant. 2009;20(2):227–231
  • Swan SK. The search continues – An ideal marker of GFR. Clin Chem. 1997;43(6):913–914

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.